4//SEC Filing
Sansone Christopher R. 4
Accession 0001628280-22-030596
CIK 0001337013other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 8:08 PM ET
Size
8.7 KB
Accession
0001628280-22-030596
Insider Transaction Report
Form 4
Sansone Christopher R.
Director
Transactions
- Sale
Common Stock
2022-11-21$8.06/sh−40,000$322,400→ 147,280 total(indirect: See) - Sale
Common Stock
2022-11-17$8.19/sh−40,838$334,463→ 187,280 total(indirect: See)
Holdings
- 25,000
Common Stock
- 1,464,916(indirect: See)
Common Stock
Footnotes (2)
- [F1]The reported securities are directly owned by Sansone Partners (QP), L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]The reported securities are directly owned by Sansone Partners, L.P., a Delaware limited partnership. The Reporting Person is the managing member of (i) the general partner of this limited partnership and (ii) the investment manager of this limited partnership and, as such, may be deemed to indirectly beneficially own the shares held by this limited partnership. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
InfuSystem Holdings, Inc
CIK 0001337013
Entity typeother
Related Parties
1- filerCIK 0001519525
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 8:08 PM ET
- Size
- 8.7 KB